Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    21609937 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Phase I/II Study of Lapatinib in Combination With Oxaliplatin and Capecitabine in Subjects With Advanced Colorectal Cancer
Conditions: Metastatic Colorectal Cancer;   Responsive to Fluoropyrimidines;   Advanced Colorectal Cancer;   Neoplasms, Colorectal
Interventions: Drug: lapatinib;   Drug: oxaliplatin;   Drug: capecitabine

Indicates status has not been verified in more than two years